CDAK
NASDAQCodiak BioSciences Inc.
Codiak BioSciences Inc. (CDAK) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. There were no new wire items for CDAK in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Codiak BioSciences Inc. (Amendment)SC 13G/A - Codiak BioSciences, Inc. (0001659352) (Subject)
- SECSEC Form 25-NSE filed by Codiak BioSciences Inc.25-NSE - Codiak BioSciences, Inc. (0001659352) (Subject)
- 13D/GSEC Form SC 13G/A filed by Codiak BioSciences Inc. (Amendment)SC 13G/A - Codiak BioSciences, Inc. (0001659352) (Subject)
- NEWSWhy Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers Secoo Holding Limited (NASDAQ:SECO) shares surged 138% to $1.43. Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) shares jumped 73.4% to $8.13 after the company announced a worldwide license agreement with Johns Hopkins University Applied Physics Laboratory for use of patented technology powering the company's bfLEAP platform. Cardlytics, Inc. (NASDAQ:CDLX) gained 34.5% to $4.64 after the company raised its Q1 revenue guidance. Butterfly Network, Inc. (NASDAQ:BFLY) jumped 31.6% to $2.4615 after the company announced it received 510(k) clearance for an AI-enabled Auto B-line Counter. Multi Ways Holdings Ltd (NYSE:MWG) gained 22.9% to $10.90. Multi Ways announced pricing of initial p
- NEWSWhy AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving PremarketGainers AMC Entertainment Hldg Pref Equity Units (NYSE:APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with converting its preferred stock into common shares. Butterfly Network, Inc. (NASDAQ:BFLY) jumped 26.2% to $2.36 in pre-market trading after the company received 510(k) clearance for AI-Enable Auto B-Line Counter. Addex Therapeutics Ltd (NASDAQ:ADXN) gained 15.7% to $1.15 in pre-market trading. Addex published dipraglurant data showing in vivo efficacy on motor and non-motor symptoms of Parkinson's disease. Meta Materials Inc. (NASDAQ:MMAT) shares climbed 13.2% to $0.5565 in pre-market trading aft
- NEWSStocks That Hit 52-Week Lows On MondayOn Monday, 76 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: CVB Financial (NASDAQ:CVBF) was the biggest company in terms of market cap to set a new 52-week low. Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest firm by market cap to set a new 52-week low. Biodexa Pharmaceuticals (NASDAQ:BDRX)'s stock moved significantly downwards, trading down 25.64% to reach a new 52-week low. Aeglea BioTherapeutics (NASDAQ:AGLE) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low. Here is a list of stocks that set new 52-week lows on Monday: CVB Financial (NASDAQ:CVBF) shares made a new 52-week low of $16.33 on Monday.
- INSIDERSEC Form 4 filed by Howze Yalonda4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- INSIDERSEC Form 4 filed by Sathyanarayanan Sriram4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- INSIDERSEC Form 4 filed by Konstantinov Konstantin4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- INSIDERSEC Form 4 filed by Bain Linda4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- INSIDERSEC Form 4 filed by Barna Nicole4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- INSIDERSEC Form 4 filed by Williams Douglas E4 - Codiak BioSciences, Inc. (0001659352) (Issuer)
- NEWSWhy Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers SCYNEXIS, Inc. (NASDAQ:SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million. Palisade Bio, Inc. (NASDAQ:PALI) rose 49% to $2.51 after Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target. National CineMedia, Inc. (NASDAQ:NCMI) jumped 32.1% to $0.1510. National CineMedia is preparing for Chapter 11 filing, the Wall Street Journal reported last week. Boxed, Inc. (NYSE:BOXD) jumped 31.9% to $0.2120 after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankrupt
- NEWSWhy Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving PremarketGainers Boxed, Inc. (NYSE:BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives. Safe & Green Holdings Corp. (NASDAQ:SGBX) shares rose 30% to $1.05 in pre-market trading after the company reported Q4 results. Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 25.1% to $0.4443 in pre-market trading. Faraday Future Intelligent Electric announced the start of production of its flagship model, the FF91 Futurist Alliance. Mullen Automotive, Inc. (NASDAQ:MULN) rose 19.2% to $0.1240 in pre-market after jumping 11% on We
- NEWSStocks That Hit 52-Week Lows On WednesdayOn Wednesday, 81 companies hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Kohl's (NYSE:KSS) was the biggest company by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was CNS Pharmaceuticals (NASDAQ:CNSP). Codiak BioSciences (NASDAQ:CDAK)'s stock came under the most pressure, trading down 22.58% to reach a new 52-week low. Future FinTech Gr (NASDAQ:FTFT) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low. The following stocks set new 52-week lows on Wednesday: Kohl's (NYSE:KSS) stock broke to a new 52-week low of $20.90 on Wednesday. Shares of
- NEWSWhy Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers LogicMark, Inc. (NASDAQ:LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. Ambipar Emergency Response (NASDAQ:AMBI) surged 40.9% to $10.95. Local Bounti Corporation (NYSE:LOCL) gained 35% to $0.6102 after the company announced it secured up to $145 million of additional financing to support growth. The company also reported Q4 financial results and issued guidance. WaveDancer, Inc. (NASDAQ:WAVD) jumped 30% to $0.3450. CBL International Limited (NASDAQ:BANL) surged 26.8% to $8.64. Kodiak Sciences Inc. (NASDAQ:KOD) gained 18.3% to $5.80 after posting a narrower-than-expe
- SECSEC Form NT 10-K filed by Codiak BioSciences Inc.NT 10-K - Codiak BioSciences, Inc. (0001659352) (Filer)
- NEWSWhy FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving PremarketGainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday. Codiak BioSciences, Inc. (NASDAQ:CDAK) gained 27% to $0.2419 in pre-market trading. Codiak BioSciences shares dropped around 57% on Monday after the company voluntarily filed for protection under Chapter 11 bankruptcy. Bird Global, Inc. (NASDAQ:BRDS) gained 20.4% to $0.1641 in pre-market trading. Bird, on Monday, announced purchases of shares by management and directors. Accelerate Diagnostics, Inc. (NASDAQ:AXDX) climbed 16% to $0.58 in pre-market trading. Accelerate Diagnostics will host a conference call on March 29, 2023 to review fourth quarter and full year
- NEWSWhy Codiak BioSciences Shares Are Trading Lower TodayCodiak BioSciences (NASDAQ:CDAK) shares are trading lower on Monday after the company voluntarily filed for protection under Chapter 11 bankruptcy. The company began a marketing process ahead of the Chapter 11 filing to determine the level of market interest and is in ongoing discussions with several parties. The company expects to consummate a sale of the entire business or its core assets as soon as reasonably practicable. "The board and management team have thoroughly assessed all of our strategic options and believe that this structured process represents the best possible solution for Codiak, taking into account our financial needs and the stage of our clinical and research programs,"
- NEWSStocks That Hit 52-Week Lows On MondayOn Monday, 89 stocks made new 52-week lows. Interesting Facts About Today's 52-Week Lows: Plug Power (NASDAQ:PLUG) is the largest company in terms of market cap to set a new 52-week low this morning. The smallest company on a market cap basis to set a new 52-week low was InVivo Therapeutics Hldg (NASDAQ:NVIV). Allarity Therapeutics (NASDAQ:ALLR)'s stock fell the most, as it traded down 2955.92% to reach a new 52-week low. Xometry (NASDAQ:XMTR) shares bounced back the most, actually rising 0.13% after hiting a new 52-week low. Stocks that set new 52-week lows on Monday are as follows: Plug Power (NASDAQ:PLUG) shares were down 4.94% for the day, having made a 52-week low of $10.
- NEWSCodiak BioSciences Files For Chapter 11 BankruptcyCodiak BioSciences Inc (NASDAQ:CDAK) voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and will seek to pursue a sale process for its assets. The company began a marketing process ahead of the Chapter 11 filing to determine the level of market interest and is in ongoing discussions with several parties. The company expects to consummate a sale of the entire business or its core assets. Codiak BioSciences' executive management team, including the CEO, CFO, Chief Medical Officer, and Chief Scientific Officer, will depart effective April 7. Douglas Williams (CEO) will remain on the Board. Kon
- SECCodiak BioSciences Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits8-K - Codiak BioSciences, Inc. (0001659352) (Filer)
- NEWSCodiak BioSciences shares are trading lower after the company voluntarily filed for protection under Chapter 11 bankruptcy.
- NEWSCodiak BioSciences Voluntarily Files For Protection Under Chapter 11 Bankruptcy
- PRCodiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 ProcessCAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that the Company has voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and will seek to pursue a sale process for its assets which is intended to maximize the value of the Company. The Company began a marketing process ahead of the Chapter 11 filing to determine the level of market interest and is in ongoing discussions with several parties. The Company expects
CDAK FAQ
8 questionsWhat does Codiak BioSciences Inc. do?
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; exoASO-NLRP3 for multiple sclerosis, neuropathy, and neurodegeneration; and exoVACC, a modular platform for...What is the latest news on CDAK?
Quantisnow has not tracked any new filings, ratings or press releases for CDAK in the last 30 days. The most recent wire item was published on February 14, 2024.Where does CDAK stock trade?
Codiak BioSciences Inc. (CDAK) is listed on NASDAQ.What sector and industry is CDAK in?
Codiak BioSciences Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Codiak BioSciences Inc. go public?
Codiak BioSciences Inc. (CDAK) completed its IPO in 2020.What are analysts saying about CDAK?
Codiak BioSciences Inc. has had 2 recent analyst actions on file. The most recent action was from Wedbush: Outperform with a $24.00 price target on 2022-02-22. Recent price targets range from $19.00 to $24.00.What companies are similar to CDAK?
Notable peers in the same industry include SMFL (Smart for Life Inc.), VLON (Vallon Pharmaceuticals Inc.), MNMD (Mind Medicine (MindMed) Inc.), GRPH (Graphite Bio Inc.), SISI (Shineco Inc.). Compare CDAK side-by-side with any of them on Quantisnow.How can I track CDAK on Quantisnow?
Quantisnow aggregates Codiak BioSciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CDAK to receive live email and push alerts on every new disclosure.